Kate Raiti

[Kate Raiti @raitiation]

@UHC I waited on hold for two hours to try and appeal a denial for a much needed acute rehab stay for my mother as your company decided to just hang up on me. What an incredible disgrace.

[Kate Raiti @raitiation]

Such a great and educational weekend with @sukritibanthiya ! Huge thanks to @HCMSummit for putting it together and @CardioNerds for the opportunity ! ���

[Sukriti Banthiya @sukritibanthiya]

…And that’s a wrap on an incredible weekend of learning at the 8th International HCM Summit🫀🤓

@raitiation @CardioNerds

#HCMSummit8 @HCMSummit

[Kate Raiti @raitiation]

It’s about joint decision making with our patients, understanding their risk of SCD and preparing for a safe environment.

[Kate Raiti @raitiation]

Exercise in patients with HCM is beneficial 🏃‍♀️🏋️‍♂️🫀@mmartinezheart @HCMSummit @CardioNerds #HCMSummit8

[Kate Raiti @raitiation]

Understanding the complexities of drug approval by FDA using surrogate end points. @HCMSummit @CardioNerds #HCMSummit8

[Kate Raiti @raitiation]

Get hyped for day 3 of HCM pearls ❣️@HCMSummit @CardioNerds #HCMSummit8

[Sukriti Banthiya @sukritibanthiya]

🔥Excited for day 3 at @HCMSummit w/ @raitiation🔥

#HCMSummit8 @CardioNerds

[Sukriti Banthiya @sukritibanthiya]

2/ ❤️ Tx for HCM + HFrEF is rooted in expert opinion, in contrast to HFrEF due to lack of robust data

🔑 GDMT in HFrEF + HCM, no reason to disqualify pts w/ HCM but may poorly tolerated

🔑 ICD associated w/ better survival

🔑 CRT may help w/ 📊 40% ⬆️ NYHA class

[Sukriti Banthiya @sukritibanthiya]

1/ ❤️ EF < 50% in HCM is an indication of significantly impaired systolic function, as these pts are hyperdynamic

… with the caveat, don’t be falsely reassured by a normal EF if severe Sx present w/ a suspected 🫀 etiology!

[Kate Raiti @raitiation]

Star struck 🤩

[Sukriti Banthiya @sukritibanthiya]

#Kittlesonrules live at @HCMSummit🔥Current management of End-Stage Heart Failure with or without systolic dysfunction: Drugs, Devices & Heart transplant🔥

#HCMSummit8 @CardioNerds

[Kate Raiti @raitiation]

Looking forward to results of ODYSSEY and ACACIA-HCM ! @MasriAhmadMD @HCMSummit @CardioNerds

[Kate Raiti @raitiation]

Non-obstructive HCM patients have symptoms too…with heart failure now the most common cause of mortality for HCM. @HCMSummit @EthanRowin @CardioNerds

[Kate Raiti @raitiation]

How to treat ? This phenotype is not just HFpEF.
🫀BB or CCB
🫀Ensure no chronotropic incompetence
🫀Optimize co-morbidities

[Kate Raiti @raitiation]

Fascinating new surgical approach via the Wei operation under echo guidance. @HCMSummit @CardioNerds

[Kate Raiti @raitiation]

In an era of CMIs, there is still a role for septal myectomy. @JosephDearaniMD @HCMSummit @CardioNerds #HCMSummit8

[Kate Raiti @raitiation]

It’s important to consider long term survival.

[Kate Raiti @raitiation]

@HCMSummit @CardioNerds 4/ Where’s the evidence for remodeling? Both Mava and Aficamten show reduction in LVMI and LAVI over time 👩🏻‍💻

[Kate Raiti @raitiation]

On the contrary, are we over prescribing beta-blockers? @IacopoOlivotto @HCMSummit @CardioNerds #HCMsummit8

[Kate Raiti @raitiation]

@HCMSummit @CardioNerds 3/
✅ sustained improvement of obstruction over time
✅ improve diastolic dysfunction
✅ improve exercise capacity
✅ reduce level of cardiac stress
✅ decrease hypertrophy

@HCMSummit @CardioNerds

[Kate Raiti @raitiation]

Patients with oHCM who need fast relief while waiting for approval of CMIs? 💊Disopyramide is still an option. #HCMSummit8 @HCMSummit @CardioNerds